Clearance Summary
EQUIMATRIX received FDA 510(k) clearance under submission number K111816, sponsored by Luitpold Pharmaceuticals, Inc.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the Dental review panel. The statutory decision date of record is 2011-09-29.
- Submission: K111816
- Applicant / Sponsor: Luitpold Pharmaceuticals, Inc.
- Clearance pathway: Abbreviated
- Review panel: Dental
- Device class: Class II
- Regulation citation: 21 CFR 872.3930
- Decision date: 2011-09-29
Classification & Regulation
This clearance is catalogued under FDA product code NPM and 21 CFR 872.3930, within the Dental review panel as a Class II device.